ArticleAlzheimer's & dementia (New York, N. Y.)

Correction to "The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE ε4 non-carriers with mild cognitive impairment due to Alzheimer's disease".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.